Find a Supplier
Add Company
SIRION Biotech licenses adenovirus technology to Danish start-up InProTher in vaccine approach to cancer
Contact Us Subscribe to Newsletter
Subscribe to Supplier

Subscribe to Supplier

.
SIRION Biotech licenses adenovirus technology to Danish start-up InProTher in vaccine approach to cancer

Research & Development News Releases

Find the latest News in Research & Development

Page 12 of 66
SIRION Biotech licenses adenovirus technology to Danish start-up InProTher in vaccine approach to cancer
SIRION Biotech licenses adenovirus technology to Danish start-up InProTher in vaccine approach to cancer

Monday 17th February 2020

By  SIRION Biotech… Learn More >
SIRION Biotech aims for IPO public share offering
SIRION Biotech aims for IPO public share offering

Thursday 30th January 2020

By  SIRION Biotech… Learn More >
Bachem brings advanced insights to Iberian Peptide Meeting Madrid
Bachem brings advanced insights to Iberian Peptide Meeting Madrid

Thursday 30th January 2020

By  Bachem AG Learn More >
Applikon adds 3L customizable single-use bioreactor to AppliFlex ST family
Applikon adds 3L customizable single-use bioreactor to AppliFlex ST family

Tuesday 28th January 2020

By  Applikon Biotechnology… Learn More >
Bachem is sponsor of Zurich Life Science Day 2020
Bachem is sponsor of Zurich Life Science Day 2020

Monday 27th January 2020

By  Bachem AG Learn More >
TAmiRNA bringing senescence biomarker insights to Longevity Therapeutics Summit
TAmiRNA bringing senescence biomarker insights to Longevity Therapeutics Summit

Wednesday 22nd January 2020

By  TAmiRNA GmbH Learn More >
VALIDOGEN presenting UNLOCK PICHIA insights at PepTalk 2020
VALIDOGEN presenting UNLOCK PICHIA insights at PepTalk 2020

Tuesday 14th January 2020

By  VALIDOGEN GmbH Learn More >
Bachem reshapes Corporate Executive Committee
Bachem reshapes Corporate Executive Committee

Wednesday 8th January 2020

By  Bachem AG Learn More >
Re-engineered TAmiRNA website goes live
Re-engineered TAmiRNA website goes live

Tuesday 7th January 2020

By  TAmiRNA GmbH Learn More >
Getinge completes acquisition of Applikon Biotechnology B.V.
Getinge completes acquisition of Applikon Biotechnology B.V.

Monday 6th January 2020

By  Applikon Biotechnology… Learn More >
Getinge to acquire Applikon Biotechnology B.V.
Getinge to acquire Applikon Biotechnology B.V.

Friday 20th December 2019

By  Applikon Biotechnology… Learn More >
Academic study confirms TAmiRNA osteomiR™ as promising biomarker for predicting fracture risk
Academic study confirms TAmiRNA osteomiR™ as promising biomarker for predicting fracture risk

Friday 13th December 2019

By  TAmiRNA GmbH Learn More >
Page 12 of 66